GNLX
GeneluxยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GNLX Profile
Genelux Corporation
A company researching a leading generation of oncolytic virus immunotherapies
Life Science Tools and Services
09/04/2001
01/26/2023
NASDAQ Stock Exchange
24
12-31
Common stock
2625 Townsgate Road, Suite 230, Westlake Village, California 91361
--
Genelux Corporation, a Delaware corporation, was founded on September 4, 2001 and is a biomedical company located in Westlake Village, California. The company is engaged in the research and development of cancer diagnosis and treatment solutions, and there is currently no effective treatment. The company focuses on the development of cancer treatments designed to generate personalized multi-pronged attacks to overwhelm the complex defense mechanisms of tumors.
